How to treat VEXAS syndrome: a systematic review on effectiveness and safety of current treatment strategies

Z Boyadzhieva, N Ruffer, I Kötter, M Krusche - Rheumatology, 2023 - academic.oup.com
Objectives To evaluate the effectiveness and safety of current treatment strategies for the
vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome. Methods A …

Clonal hematopoiesis, inflammation, and hematologic malignancy

R Kanagal-Shamanna, DB Beck… - Annual Review of …, 2024 - annualreviews.org
Somatic or acquired mutations are postzygotic genetic variations that can occur within any
tissue. These mutations accumulate during aging and have classically been linked to …

Novel causative variants of VEXAS in UBA1 detected through whole genome transcriptome sequencing in a large cohort of hematological malignancies

M Sakuma, P Blombery, M Meggendorfer, C Haferlach… - Leukemia, 2023 - nature.com
UBA1 is an X-linked gene and encodes an ubiquitin-activating enzyme. Three somatic
mutations altering the alternative start codon (M41) in UBA1 in hematopoietic precursor cells …

Early activation of inflammatory pathways in UBA1-mutated hematopoietic stem and progenitor cells in VEXAS

Z Wu, S Gao, Q Gao, BA Patel, EM Groarke, X Feng… - Cell Reports …, 2023 - cell.com
Summary VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome is a
pleiotropic, severe autoinflammatory disease caused by somatic mutations in the ubiquitin …

VEXAS syndrome: clinical, hematologic features and a practical approach to diagnosis and management

MJ Koster, TL Lasho, H Olteanu… - American journal of …, 2024 - Wiley Online Library
Abstract VEXAS (Vacuoles, E1 enzyme, X‐linked, Autoinflammatory, Somatic) syndrome is a
newly identified disease caused by somatic alterations in UBA1 which produce a recalcitrant …

Inborn errors of immunity: an expanding universe of disease and genetic architecture

YT Akalu, D Bogunovic - Nature Reviews Genetics, 2024 - nature.com
Inborn errors of immunity (IEIs) are generally considered to be rare monogenic disorders of
the immune system that cause immunodeficiency, autoinflammation, autoimmunity, allergy …

Serious infections in patients with VEXAS syndrome: data from the French VEXAS registry

B de Valence, M Delaune, Y Nguyen, V Jachiet… - Annals of the rheumatic …, 2024 - Elsevier
Introduction Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome
is an acquired autoinflammatory monogenic disease with a poor prognosis whose …

Pulmonary manifestations in VEXAS syndrome

MC Moura, M Baqir, YK Tandon, MJ Samec… - Respiratory …, 2023 - Elsevier
Abstract Background Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS)
syndrome is a recently recognized multisystem disorder caused by somatic mutations in the …

Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromes

M Sirenko, E Bernard, M Creignou, D Domenico… - Blood, 2024 - ashpublications.org
Mutations in UBA1, which are disease-defining for VEXAS (vacuoles, E1 enzyme, X-linked,
autoinflammatory, somatic) syndrome, have been reported in patients diagnosed with …

Genetically transitional disease: conceptual understanding and applicability to rheumatic disease

TB Niewold, I Aksentijevich, PD Gorevic… - Nature Reviews …, 2024 - nature.com
In genomic medicine, the concept of genetically transitional disease (GTD) refers to cases in
which gene mutation is necessary but not sufficient to cause disease. In this Perspective, we …